Africa's first large-scale HIV vaccine study launches

The launch of the first large-scale study to evaluate a candidate HIV vaccine on the African continent was announced today by study collaborators in the United States and South Africa. The trial will involve up to 3,000 participants at five sites throughout South Africa and is expected to continue for four years.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news90153511.html">Africa's first large-scale HIV vaccine study launches</a></p> <p>The launch of the first large-scale study to evaluate a candidate HIV vaccine on the African continent was announced today by study collaborators in the United States and South Africa. The trial will involve up to 3,000 participants at five sites throughout South Africa and is expected to continue for four years.</p>